Phase 3 study of S-888711 in thrombocytopenic patients with chronic liver disease

Trial Profile

Phase 3 study of S-888711 in thrombocytopenic patients with chronic liver disease

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Lusutrombopag (Primary)
  • Indications Thrombocytopenia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms L-PLUS1
  • Sponsors Shionogi
  • Most Recent Events

    • 25 Sep 2017 According to a Shionogi media release, based on the results from the L-PLUS1 and L-PLUS2 Phase 3 studies, Shionogi has initiated rolling submission of a New Drug Application to the FDA.
    • 25 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top